Partner Interview
Published July 8, 2025
Roper Technologies: CentralReach Acquisition
inpractise.com/articles/roper-technologies-centralreach-acquisition
Executive Bio
Former VP at CentralReach
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
This is a snippet of the transcript.to get full access.
That's a really good background and very useful. Can you elaborate more on what CentralReach does, what the products offer, and how critical the software is to its customers?
CentralReach's Electronic Medical Record is essentially the operating system for a company. It has two fundamental modules. The core module is Practice Management, which manages authorizations from insurance payers, scheduling therapies, timesheets, billing to insurance, and reconciling denials or payments. This module handles the administrative aspects of the work.
This is a snippet of the transcript.to get full access.
That's a really good background and very useful. Can you elaborate more on what CentralReach does, what the products offer, and how critical the software is to its customers?
The other core module is clinical documentation or data collection. What makes ABA unique from other specialty EMRs is the quantified information collected. For example, if I'm teaching a learner to wash their hands, they might do it four times in two hours, with each washing having seven steps. You track each step, noting whether they did it independently, needed prompting, or required help. This data is collected at a detailed level and used to track progress over time, showing how independently they perform tasks.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.
